CD36 and obesity disorder: As a consequence of its many ligands and functions, CD36 could impact on a wide range of dysmetabolic conditions associated with obesity, such as dyslipidaemia, insulin resistance, diabetes, inflammation, atherosclerosis and cancer (Hirano et al., 2003; Pascual et al., 2017).